COSTEM 2019 | Can CAR-T cells replace ASCT in DLBCL?

Stephen Schuster

Stephen Schuster, MD, University of Pennsylvania, Philadelphia, PA, discusses his views on whether CAR-T cells can replace autologous stem cell transplantation (ASCT) in diffuse large B-cell lymphoma (DLBCL). This interview took place at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

Share this video